Webb Carol 4
4 · CITIUS ONCOLOGY, INC. · Filed Dec 16, 2024
Insider Transaction Report
Form 4
Webb Carol
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-12-12+125,000→ 125,000 totalExercise: $1.07Exp: 2034-12-12→ Common Stock (125,000 underlying)
Holdings
- 150,000
Stock Option (Right to Buy)
Exercise: $2.15Exp: 2033-07-05→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
- [F2]These options are 100% vested.